{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:55:46Z","timestamp":1772556946397,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.clnesp.2022.07.010","type":"journal-article","created":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T02:53:25Z","timestamp":1659236005000},"page":"412-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Relationship between the creatinine\/cystatin C ratio and muscle mass measured by CT-scan in cancer patients"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3342-1704","authenticated-orcid":false,"given":"Camille","family":"Tlemsani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Raynard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Pierre","family":"Revel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"Deluche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8639-1898","authenticated-orcid":false,"given":"Mario","family":"Di Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Pigneur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Goldwasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2022.07.010_bib1","first-page":"28","article-title":"Hormones and sarcopenia","volume":"4","author":"Morley","year":"2017","journal-title":"Curr Pharm Des"},{"issue":"7","key":"10.1016\/j.clnesp.2022.07.010_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/thoraxjnl-2015-206929","article-title":"Sarcopenia in COPD","volume":"70","author":"Scarlata","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.clnesp.2022.07.010_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2018.12.003","article-title":"Body composition and sarcopenia: the next-generation of personalized oncology and pharmacology?","volume":"196","author":"Hilmi","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.clnesp.2022.07.010_bib4","first-page":"3161","article-title":"Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoieticstem cell transplantation","volume":"20","author":"Morishita","year":"2012","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.clnesp.2022.07.010_bib5","first-page":"3119","article-title":"The prevalence of CT-defined low skeletal muscle mass in patients with metastatic cancer: a cross-sectional multicenter French study (the SCAN Study)","volume":"30","author":"Raynard","year":"2022","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.clnesp.2022.07.010_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.clnesp.2022.07.010_bib7","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/annonc\/mdx271","article-title":"Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy","volume":"28","author":"Bozzetti","year":"2017","journal-title":"Ann Oncol"},{"issue":"suppl_2","key":"10.1016\/j.clnesp.2022.07.010_bib8","article-title":"Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy","volume":"29","author":"Baracos","year":"2018","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.clnesp.2022.07.010_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"issue":"22","key":"10.1016\/j.clnesp.2022.07.010_bib10","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","article-title":"Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer","volume":"15","author":"Tan","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.clnesp.2022.07.010_bib11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: Europeanconsensus on definition and diagnosis: Report of the EuropeanWorkingGroup on sarcopenia in OlderPeople. European Working group on sarcopenia in older people","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"issue":"5","key":"10.1016\/j.clnesp.2022.07.010_bib12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"10.1016\/j.clnesp.2022.07.010_bib13","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A\u00a0practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metabol"},{"issue":"12","key":"10.1016\/j.clnesp.2022.07.010_bib14","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.clnesp.2022.07.010_bib15","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/CCM.0000000000002013","article-title":"Evaluating muscle mass by using markers of kidney function: development of the sarcopenia index","volume":"45","author":"Kashani","year":"2017","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.clnesp.2022.07.010_bib16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/mus.21420","article-title":"Utility of cystatin C to monitor renal function in Duchenne muscular dystrophy","volume":"40","author":"Viollet","year":"2009","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.clnesp.2022.07.010_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13182","article-title":"The sarcopenia index: a novel measure of muscle mass in lung transplant candidates","volume":"32","author":"Kashani","year":"2018","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.clnesp.2022.07.010_bib18","first-page":"2","article-title":"Relationship between sarcopenia and the serum creatinine\/cystatin C ratio in Japanese rural community-dwelling older adults","volume":"3","author":"Kusunoki","year":"2018","journal-title":"JCSM Clin Rep"},{"key":"10.1016\/j.clnesp.2022.07.010_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.diabres.2018.02.025","article-title":"Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes","volume":"139","author":"Osaka","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clnesp.2022.07.010_bib20","article-title":"Chronic kidney disease Epidemiology Collaboration. New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"23","author":"Inker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.clnesp.2022.07.010_bib21","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/bjc.2013.58","article-title":"Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients","volume":"108","author":"Huillard","year":"2013","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.clnesp.2022.07.010_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037563","article-title":"Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma","volume":"7","author":"Mir","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clnesp.2022.07.010_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jcsm.12158","article-title":"A\u00a0comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients","volume":"8","author":"van Vugt","year":"2017","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.clnesp.2022.07.010_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/gerona\/61.1.72","article-title":"Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort","volume":"61","author":"Newman","year":"2006","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"10.1016\/j.clnesp.2022.07.010_bib25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1046\/j.1532-5415.2002.50217.x","article-title":"Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health, aging and body composition study","volume":"50","author":"Visser","year":"2002","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.clnesp.2022.07.010_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2020.111032","article-title":"A\u00a0new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer","volume":"82","author":"Fu","year":"2021","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.clnesp.2022.07.010_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12876-022-02093-4","article-title":"Serum creatinine\/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer","volume":"22","author":"JSun","year":"2022","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.clnesp.2022.07.010_bib28","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/jcsm.12977","article-title":"Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer","volume":"13","author":"Tang","year":"2022","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.clnesp.2022.07.010_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12877-022-02925-8","article-title":"Serum creatinine\/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer","volume":"22","author":"Zheng","year":"2022","journal-title":"BMC Geriatr"},{"issue":"5","key":"10.1016\/j.clnesp.2022.07.010_bib30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/codi.14558","article-title":"A\u00a0new diagnostic index for sarcopenia and its association with short-term postoperative complications in patients undergoing surgery for colorectal cancer","volume":"21","author":"Yang","year":"2019","journal-title":"Colorectal Dis"},{"issue":"2","key":"10.1016\/j.clnesp.2022.07.010_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/hepr.13230","article-title":"Ratio between estimated glomerular filtration rates of creatinine and cystatin C predicts overall survival in patients with hepatocellular carcinoma","volume":"49","author":"Tamai","year":"2019","journal-title":"Hepatol Res"},{"issue":"19","key":"10.1016\/j.clnesp.2022.07.010_bib32","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"NewCreatinine- and CystatinC-BasedEquations to EstimateGFR without Race.Chronic kidney disease Epidemiology Collaboration","volume":"385","author":"Inker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.clnesp.2022.07.010_bib33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.amjmed.2016.11.020","article-title":"Prognostic importance of low admission serum creatinine Concentration for mortality in Hospitalized patients","volume":"130","author":"Thongprayoon","year":"2017","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.clnesp.2022.07.010_bib34","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.amjmed.2017.01.018","article-title":"Looking for sarcopenia biomarkers","volume":"130","author":"Lien","year":"2017","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.clnesp.2022.07.010_bib35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"European Working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working group on sarcopenia in older people","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"issue":"4","key":"10.1016\/j.clnesp.2022.07.010_bib36","first-page":"573","article-title":"Utility of creatinine\/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: a retrospective study","volume":"43","author":"Suzuki","year":"2015","journal-title":"J\u00a0Int Med Res"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545772200420X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545772200420X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:05:53Z","timestamp":1762499153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240545772200420X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":36,"alternative-id":["S240545772200420X"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2022.07.010","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between the creatinine\/cystatin C ratio and muscle mass measured by CT-scan in cancer patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2022.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}